Rhinosinusitis Drug Market - Global Outlook and Forecast 2022-2028

March 2022 | 63 pages | ID: R1361A855147EN
Market Monitor Global

Abstracts

Rhinosinusitis, is inflammation of the sinuses resulting in symptoms. Common signs and symptoms include thick nasal mucus, a plugged nose, and pain in the face. Other signs and symptoms may include fever, headaches, poor sense of smell, sore throat, and cough. The cough is often worse at night. Serious complications are rare. It is defined as acute rhinosinusitis (ARS) if it lasts less than 4 weeks, and chronic rhinosinusitis (CRS) if it lasts for more than 12 weeks.

This report contains market size and forecasts of Rhinosinusitis Drug in Global, including the following market information:

Global Rhinosinusitis Drug Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global Rhinosinusitis Drug market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Antibiotics Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Rhinosinusitis Drug include Sanofi, Bayer, Pfizer, AstraZeneca, Novartis, Johnson & Johnson, Merck, Amgen and Bionorica, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Rhinosinusitis Drug companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Rhinosinusitis Drug Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Rhinosinusitis Drug Market Segment Percentages, by Type, 2021 (%)

• Antibiotics
• Corticosteroids
• Decongestants
• Other

Global Rhinosinusitis Drug Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Rhinosinusitis Drug Market Segment Percentages, by Application, 2021 (%)

• Acute Sinusitis
• Chronic Sinusitis

Global Rhinosinusitis Drug Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Rhinosinusitis Drug Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Rhinosinusitis Drug revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies Rhinosinusitis Drug revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Sanofi
• Bayer
• Pfizer
• AstraZeneca
• Novartis
• Johnson & Johnson
• Merck
• Amgen
• Bionorica
• Dr. Reddy's Laboratories
• Huasun

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Rhinosinusitis Drug Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Rhinosinusitis Drug Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL RHINOSINUSITIS DRUG OVERALL MARKET SIZE

2.1 Global Rhinosinusitis Drug Market Size: 2021 VS 2028
2.2 Global Rhinosinusitis Drug Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Rhinosinusitis Drug Players in Global Market
3.2 Top Global Rhinosinusitis Drug Companies Ranked by Revenue
3.3 Global Rhinosinusitis Drug Revenue by Companies
3.4 Top 3 and Top 5 Rhinosinusitis Drug Companies in Global Market, by Revenue in 2021
3.5 Global Companies Rhinosinusitis Drug Product Type
3.6 Tier 1, Tier 2 and Tier 3 Rhinosinusitis Drug Players in Global Market
  3.6.1 List of Global Tier 1 Rhinosinusitis Drug Companies
  3.6.2 List of Global Tier 2 and Tier 3 Rhinosinusitis Drug Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 by Type - Global Rhinosinusitis Drug Market Size Markets, 2021 & 2028
  4.1.2 Antibiotics
  4.1.3 Corticosteroids
  4.1.4 Decongestants
  4.1.5 Other
4.2 By Type - Global Rhinosinusitis Drug Revenue & Forecasts
  4.2.1 By Type - Global Rhinosinusitis Drug Revenue, 2017-2022
  4.2.2 By Type - Global Rhinosinusitis Drug Revenue, 2023-2028
  4.2.3 By Type - Global Rhinosinusitis Drug Revenue Market Share, 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Rhinosinusitis Drug Market Size, 2021 & 2028
  5.1.2 Acute Sinusitis
  5.1.3 Chronic Sinusitis
5.2 By Application - Global Rhinosinusitis Drug Revenue & Forecasts
  5.2.1 By Application - Global Rhinosinusitis Drug Revenue, 2017-2022
  5.2.2 By Application - Global Rhinosinusitis Drug Revenue, 2023-2028
  5.2.3 By Application - Global Rhinosinusitis Drug Revenue Market Share, 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Rhinosinusitis Drug Market Size, 2021 & 2028
6.2 By Region - Global Rhinosinusitis Drug Revenue & Forecasts
  6.2.1 By Region - Global Rhinosinusitis Drug Revenue, 2017-2022
  6.2.2 By Region - Global Rhinosinusitis Drug Revenue, 2023-2028
  6.2.3 By Region - Global Rhinosinusitis Drug Revenue Market Share, 2017-2028
6.3 North America
  6.3.1 By Country - North America Rhinosinusitis Drug Revenue, 2017-2028
  6.3.2 US Rhinosinusitis Drug Market Size, 2017-2028
  6.3.3 Canada Rhinosinusitis Drug Market Size, 2017-2028
  6.3.4 Mexico Rhinosinusitis Drug Market Size, 2017-2028
6.4 Europe
  6.4.1 By Country - Europe Rhinosinusitis Drug Revenue, 2017-2028
  6.4.2 Germany Rhinosinusitis Drug Market Size, 2017-2028
  6.4.3 France Rhinosinusitis Drug Market Size, 2017-2028
  6.4.4 U.K. Rhinosinusitis Drug Market Size, 2017-2028
  6.4.5 Italy Rhinosinusitis Drug Market Size, 2017-2028
  6.4.6 Russia Rhinosinusitis Drug Market Size, 2017-2028
  6.4.7 Nordic Countries Rhinosinusitis Drug Market Size, 2017-2028
  6.4.8 Benelux Rhinosinusitis Drug Market Size, 2017-2028
6.5 Asia
  6.5.1 By Region - Asia Rhinosinusitis Drug Revenue, 2017-2028
  6.5.2 China Rhinosinusitis Drug Market Size, 2017-2028
  6.5.3 Japan Rhinosinusitis Drug Market Size, 2017-2028
  6.5.4 South Korea Rhinosinusitis Drug Market Size, 2017-2028
  6.5.5 Southeast Asia Rhinosinusitis Drug Market Size, 2017-2028
  6.5.6 India Rhinosinusitis Drug Market Size, 2017-2028
6.6 South America
  6.6.1 By Country - South America Rhinosinusitis Drug Revenue, 2017-2028
  6.6.2 Brazil Rhinosinusitis Drug Market Size, 2017-2028
  6.6.3 Argentina Rhinosinusitis Drug Market Size, 2017-2028
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Rhinosinusitis Drug Revenue, 2017-2028
  6.7.2 Turkey Rhinosinusitis Drug Market Size, 2017-2028
  6.7.3 Israel Rhinosinusitis Drug Market Size, 2017-2028
  6.7.4 Saudi Arabia Rhinosinusitis Drug Market Size, 2017-2028
  6.7.5 UAE Rhinosinusitis Drug Market Size, 2017-2028

7 PLAYERS PROFILES

7.1 Sanofi
  7.1.1 Sanofi Corporate Summary
  7.1.2 Sanofi Business Overview
  7.1.3 Sanofi Rhinosinusitis Drug Major Product Offerings
  7.1.4 Sanofi Rhinosinusitis Drug Revenue in Global Market (2017-2022)
  7.1.5 Sanofi Key News
7.2 Bayer
  7.2.1 Bayer Corporate Summary
  7.2.2 Bayer Business Overview
  7.2.3 Bayer Rhinosinusitis Drug Major Product Offerings
  7.2.4 Bayer Rhinosinusitis Drug Revenue in Global Market (2017-2022)
  7.2.5 Bayer Key News
7.3 Pfizer
  7.3.1 Pfizer Corporate Summary
  7.3.2 Pfizer Business Overview
  7.3.3 Pfizer Rhinosinusitis Drug Major Product Offerings
  7.3.4 Pfizer Rhinosinusitis Drug Revenue in Global Market (2017-2022)
  7.3.5 Pfizer Key News
7.4 AstraZeneca
  7.4.1 AstraZeneca Corporate Summary
  7.4.2 AstraZeneca Business Overview
  7.4.3 AstraZeneca Rhinosinusitis Drug Major Product Offerings
  7.4.4 AstraZeneca Rhinosinusitis Drug Revenue in Global Market (2017-2022)
  7.4.5 AstraZeneca Key News
7.5 Novartis
  7.5.1 Novartis Corporate Summary
  7.5.2 Novartis Business Overview
  7.5.3 Novartis Rhinosinusitis Drug Major Product Offerings
  7.5.4 Novartis Rhinosinusitis Drug Revenue in Global Market (2017-2022)
  7.5.5 Novartis Key News
7.6 Johnson & Johnson
  7.6.1 Johnson & Johnson Corporate Summary
  7.6.2 Johnson & Johnson Business Overview
  7.6.3 Johnson & Johnson Rhinosinusitis Drug Major Product Offerings
  7.6.4 Johnson & Johnson Rhinosinusitis Drug Revenue in Global Market (2017-2022)
  7.6.5 Johnson & Johnson Key News
7.7 Merck
  7.7.1 Merck Corporate Summary
  7.7.2 Merck Business Overview
  7.7.3 Merck Rhinosinusitis Drug Major Product Offerings
  7.7.4 Merck Rhinosinusitis Drug Revenue in Global Market (2017-2022)
  7.7.5 Merck Key News
7.8 Amgen
  7.8.1 Amgen Corporate Summary
  7.8.2 Amgen Business Overview
  7.8.3 Amgen Rhinosinusitis Drug Major Product Offerings
  7.8.4 Amgen Rhinosinusitis Drug Revenue in Global Market (2017-2022)
  7.8.5 Amgen Key News
7.9 Bionorica
  7.9.1 Bionorica Corporate Summary
  7.9.2 Bionorica Business Overview
  7.9.3 Bionorica Rhinosinusitis Drug Major Product Offerings
  7.9.4 Bionorica Rhinosinusitis Drug Revenue in Global Market (2017-2022)
  7.9.5 Bionorica Key News
7.10 Dr. Reddy's Laboratories
  7.10.1 Dr. Reddy's Laboratories Corporate Summary
  7.10.2 Dr. Reddy's Laboratories Business Overview
  7.10.3 Dr. Reddy's Laboratories Rhinosinusitis Drug Major Product Offerings
  7.10.4 Dr. Reddy's Laboratories Rhinosinusitis Drug Revenue in Global Market (2017-2022)
  7.10.5 Dr. Reddy's Laboratories Key News
7.11 Huasun
  7.11.1 Huasun Corporate Summary
  7.11.2 Huasun Business Overview
  7.11.3 Huasun Rhinosinusitis Drug Major Product Offerings
  7.11.4 Huasun Rhinosinusitis Drug Revenue in Global Market (2017-2022)
  7.11.5 Huasun Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Rhinosinusitis Drug Market Opportunities & Trends in Global Market
Table 2. Rhinosinusitis Drug Market Drivers in Global Market
Table 3. Rhinosinusitis Drug Market Restraints in Global Market
Table 4. Key Players of Rhinosinusitis Drug in Global Market
Table 5. Top Rhinosinusitis Drug Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Rhinosinusitis Drug Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Rhinosinusitis Drug Revenue Share by Companies, 2017-2022
Table 8. Global Companies Rhinosinusitis Drug Product Type
Table 9. List of Global Tier 1 Rhinosinusitis Drug Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Rhinosinusitis Drug Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Rhinosinusitis Drug Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Rhinosinusitis Drug Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Rhinosinusitis Drug Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Rhinosinusitis Drug Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Rhinosinusitis Drug Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Rhinosinusitis Drug Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Rhinosinusitis Drug Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Rhinosinusitis Drug Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Rhinosinusitis Drug Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Rhinosinusitis Drug Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Rhinosinusitis Drug Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Rhinosinusitis Drug Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Rhinosinusitis Drug Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Rhinosinusitis Drug Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Rhinosinusitis Drug Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Rhinosinusitis Drug Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Rhinosinusitis Drug Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Rhinosinusitis Drug Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Rhinosinusitis Drug Revenue, (US$, Mn), 2023-2028
Table 30. Sanofi Corporate Summary
Table 31. Sanofi Rhinosinusitis Drug Product Offerings
Table 32. Sanofi Rhinosinusitis Drug Revenue (US$, Mn), (2017-2022)
Table 33. Bayer Corporate Summary
Table 34. Bayer Rhinosinusitis Drug Product Offerings
Table 35. Bayer Rhinosinusitis Drug Revenue (US$, Mn), (2017-2022)
Table 36. Pfizer Corporate Summary
Table 37. Pfizer Rhinosinusitis Drug Product Offerings
Table 38. Pfizer Rhinosinusitis Drug Revenue (US$, Mn), (2017-2022)
Table 39. AstraZeneca Corporate Summary
Table 40. AstraZeneca Rhinosinusitis Drug Product Offerings
Table 41. AstraZeneca Rhinosinusitis Drug Revenue (US$, Mn), (2017-2022)
Table 42. Novartis Corporate Summary
Table 43. Novartis Rhinosinusitis Drug Product Offerings
Table 44. Novartis Rhinosinusitis Drug Revenue (US$, Mn), (2017-2022)
Table 45. Johnson & Johnson Corporate Summary
Table 46. Johnson & Johnson Rhinosinusitis Drug Product Offerings
Table 47. Johnson & Johnson Rhinosinusitis Drug Revenue (US$, Mn), (2017-2022)
Table 48. Merck Corporate Summary
Table 49. Merck Rhinosinusitis Drug Product Offerings
Table 50. Merck Rhinosinusitis Drug Revenue (US$, Mn), (2017-2022)
Table 51. Amgen Corporate Summary
Table 52. Amgen Rhinosinusitis Drug Product Offerings
Table 53. Amgen Rhinosinusitis Drug Revenue (US$, Mn), (2017-2022)
Table 54. Bionorica Corporate Summary
Table 55. Bionorica Rhinosinusitis Drug Product Offerings
Table 56. Bionorica Rhinosinusitis Drug Revenue (US$, Mn), (2017-2022)
Table 57. Dr. Reddy's Laboratories Corporate Summary
Table 58. Dr. Reddy's Laboratories Rhinosinusitis Drug Product Offerings
Table 59. Dr. Reddy's Laboratories Rhinosinusitis Drug Revenue (US$, Mn), (2017-2022)
Table 60. Huasun Corporate Summary
Table 61. Huasun Rhinosinusitis Drug Product Offerings
Table 62. Huasun Rhinosinusitis Drug Revenue (US$, Mn), (2017-2022)

List Of Figures

LIST OF FIGURES

Figure 1. Rhinosinusitis Drug Segment by Type in 2021
Figure 2. Rhinosinusitis Drug Segment by Application in 2021
Figure 3. Global Rhinosinusitis Drug Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Rhinosinusitis Drug Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Rhinosinusitis Drug Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Rhinosinusitis Drug Revenue in 2021
Figure 8. By Type - Global Rhinosinusitis Drug Revenue Market Share, 2017-2028
Figure 9. By Application - Global Rhinosinusitis Drug Revenue Market Share, 2017-2028
Figure 10. By Region - Global Rhinosinusitis Drug Revenue Market Share, 2017-2028
Figure 11. By Country - North America Rhinosinusitis Drug Revenue Market Share, 2017-2028
Figure 12. US Rhinosinusitis Drug Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Rhinosinusitis Drug Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Rhinosinusitis Drug Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Rhinosinusitis Drug Revenue Market Share, 2017-2028
Figure 16. Germany Rhinosinusitis Drug Revenue, (US$, Mn), 2017-2028
Figure 17. France Rhinosinusitis Drug Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Rhinosinusitis Drug Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Rhinosinusitis Drug Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Rhinosinusitis Drug Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Rhinosinusitis Drug Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Rhinosinusitis Drug Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Rhinosinusitis Drug Revenue Market Share, 2017-2028
Figure 24. China Rhinosinusitis Drug Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Rhinosinusitis Drug Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Rhinosinusitis Drug Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Rhinosinusitis Drug Revenue, (US$, Mn), 2017-2028
Figure 28. India Rhinosinusitis Drug Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Rhinosinusitis Drug Revenue Market Share, 2017-2028
Figure 30. Brazil Rhinosinusitis Drug Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Rhinosinusitis Drug Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Rhinosinusitis Drug Revenue Market Share, 2017-2028
Figure 33. Turkey Rhinosinusitis Drug Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Rhinosinusitis Drug Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Rhinosinusitis Drug Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Rhinosinusitis Drug Revenue, (US$, Mn), 2017-2028
Figure 37. Sanofi Rhinosinusitis Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Bayer Rhinosinusitis Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Pfizer Rhinosinusitis Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. AstraZeneca Rhinosinusitis Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Novartis Rhinosinusitis Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Johnson & Johnson Rhinosinusitis Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Merck Rhinosinusitis Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. Amgen Rhinosinusitis Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. Bionorica Rhinosinusitis Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 46. Dr. Reddy's Laboratories Rhinosinusitis Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 47. Huasun Rhinosinusitis Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)